Cas no 54364-80-6 (benzoic acid, 2,3-dibromo-, ethyl ester)
benzoic acid, 2,3-dibromo-, ethyl ester Chemical and Physical Properties
Names and Identifiers
-
- benzoic acid, 2,3-dibromo-, ethyl ester
- LogP
- 2,3-DIBROMO-BENZOIC ACID ETHYL ESTER
- Ethyl 2,3-dibromobenzoate
- CS-0190523
- DTXSID50673263
- DB-313027
- MFCD11520722
- E90510
- 54364-80-6
-
- MDL: MFCD11520722
- Inchi: 1S/C9H8Br2O2/c1-2-13-9(12)6-4-3-5-7(10)8(6)11/h3-5H,2H2,1H3
- InChI Key: GBGOOSVSPZDQOO-UHFFFAOYSA-N
- SMILES: BrC1C(=CC=CC=1C(=O)OCC)Br
Computed Properties
- Exact Mass: 305.88904
- Monoisotopic Mass: 305.88910g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 13
- Rotatable Bond Count: 3
- Complexity: 185
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.5
- Topological Polar Surface Area: 26.3?2
Experimental Properties
- PSA: 26.3
benzoic acid, 2,3-dibromo-, ethyl ester Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Aaron | AR00DUBD-500mg |
2,3-DIBROMO-BENZOIC ACID ETHYL ESTER |
54364-80-6 | 95% | 500mg |
$564.00 | 2025-02-12 | |
| Aaron | AR00DUBD-1g |
2,3-DIBROMO-BENZOIC ACID ETHYL ESTER |
54364-80-6 | 95% | 1g |
$750.00 | 2025-02-12 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1261193-500mg |
Ethyl 2,3-dibromobenzoate |
54364-80-6 | 98% | 500mg |
¥4824.00 | 2024-05-09 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1261193-1g |
Ethyl 2,3-dibromobenzoate |
54364-80-6 | 98% | 1g |
¥6428.00 | 2024-05-09 | |
| abcr | AB606543-250mg |
Ethyl 2,3-dibromobenzoate; . |
54364-80-6 | 250mg |
€367.90 | 2025-04-18 | ||
| abcr | AB606543-1g |
Ethyl 2,3-dibromobenzoate; . |
54364-80-6 | 1g |
€682.30 | 2025-04-18 | ||
| abcr | AB606543-5g |
Ethyl 2,3-dibromobenzoate; . |
54364-80-6 | 5g |
€2297.60 | 2025-04-18 |
benzoic acid, 2,3-dibromo-, ethyl ester Related Literature
-
Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
-
Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
-
Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
Additional information on benzoic acid, 2,3-dibromo-, ethyl ester
Benzoic acid, 2,3-dibromo-, ethyl ester (CAS No. 54364-80-6): A Comprehensive Overview in Modern Chemical Biology
Benzoic acid, 2,3-dibromo-, ethyl ester, identified by the Chemical Abstracts Service Number (CAS No.) 54364-80-6, is a specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its brominated benzoic acid ester structure, exhibits unique chemical properties that make it a valuable intermediate in synthetic chemistry and a potential candidate for various biological applications.
The molecular structure of benzoic acid, 2,3-dibromo-, ethyl ester consists of a benzene ring substituted with two bromine atoms at the 2 and 3 positions, followed by an ethyl ester group at the carboxyl position. This specific arrangement imparts distinct reactivity and functionalization possibilities, making it a versatile building block in the synthesis of more complex molecules. The presence of bromine atoms enhances the electrophilicity of the aromatic ring, facilitating various coupling reactions such as Suzuki-Miyaura cross-coupling, which is widely used in pharmaceutical synthesis.
In recent years, there has been growing interest in the applications of brominated benzoic acid derivatives in medicinal chemistry. The bromine atoms not only serve as handles for further functionalization but also contribute to the compound's bioactivity. Studies have shown that such derivatives can exhibit antimicrobial, anti-inflammatory, and even anticancer properties. For instance, modifications of the benzoic acid scaffold have led to the discovery of novel compounds with enhanced binding affinity to biological targets.
One of the most compelling aspects of benzoic acid, 2,3-dibromo-, ethyl ester is its role as a precursor in the synthesis of biologically active molecules. Researchers have leveraged its reactive sites to develop inhibitors targeting enzymes involved in metabolic pathways relevant to diseases such as diabetes and cancer. The ability to introduce additional functional groups through cross-coupling reactions allows for fine-tuning of physicochemical properties, including solubility and metabolic stability.
The pharmaceutical industry has also explored the potential of brominated benzoic acid esters in drug development. The structural motif is found in several lead compounds that have progressed into clinical trials due to their promising pharmacological profiles. For example, derivatives of this class have shown efficacy in modulating neurotransmitter receptors, which could have implications for treating neurological disorders.
The synthesis of benzoic acid, 2,3-dibromo-, ethyl ester typically involves multi-step organic reactions starting from commercially available benzoic acid derivatives. Key steps include bromination at specific positions on the benzene ring followed by esterification. Advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions have been employed to achieve high regioselectivity and yield.
In academic research, this compound has been utilized as a model system to study reaction mechanisms and develop new synthetic methodologies. Its unique reactivity profile provides insights into how structural modifications can influence molecular behavior, which is crucial for designing drugs with improved therapeutic efficacy and reduced side effects.
The future prospects for benzoic acid, 2,3-dibromo-, ethyl ester are promising, with ongoing studies focusing on expanding its applications in drug discovery and material science. Innovations in synthetic chemistry continue to unlock new possibilities for this versatile intermediate, ensuring its continued relevance in both academic and industrial settings.
54364-80-6 (benzoic acid, 2,3-dibromo-, ethyl ester) Related Products
- 29092-13-5(1,4-Benzenedicarboxylicacid, 2,3,5,6-tetrabromo-, 1-ethyl ester)
- 155694-83-0(Benzoic acid,2-bromo-3-methyl-, ethyl ester)
- 154239-21-1(1,4-Diethyl 2-bromobenzene-1,4-dicarboxylate)
- 90772-73-9(4-(Acetoxymethyl)-3-bromobenzoic acid)
- 94441-98-2(1,4-Benzenedicarboxylicacid, 2,3,5,6-tetrabromo-, 1,4-bis[(2,3,4,5,6-pentabromophenyl)methyl] ester)
- 90075-91-5(1,4-Benzenedicarboxylic acid, bis[(pentabromophenyl)methyl] ester)
- 18013-97-3(Diethyl 2,5-Dibromoterephthalate)
- 881667-36-3(Methyl 2,3-dibromobenzoate)
- 140477-71-0(Benzoic acid, tetrabromo-, 2-bromoethyl ester)
- 155694-82-9(Ethyl 2-bromo-4-methylbenzoate)